Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years

被引：0
|
作者：
Charles Oo
George Hill
Albert Dorr
Baolian Liu
Samuel Boellner
Penelope Ward
机构：
[1] Roche Global Development,
[2] Aventis Pharmaceutical Inc. 1041,undefined
[3] Roche Global Development,undefined
[4] XIQ Coordination Inc.,undefined
[5] Clinical Study Center,undefined
[6] Roche Global Development,undefined
来源：
European Journal of Clinical Pharmacology | 2003年 / 59卷
关键词：
Oseltamivir; Children;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：411 / 415
页数：4
相关论文
共 50 条
  • [31] Novel oral anti-influenza prodrug candidate AV5075S
    Ivachtchenko, Alexandre V.
    Ivanenkov, Yan A.
    Mitkin, Oleg D.
    Yamanushkin, Pavel M.
    Bichko, Vadim V.
    Shevkun, Natalia A.
    Mokrushina, Olga V.
    Nevolina, Olga O.
    Karapetian, Ruben N.
    Leneva, Irina A.
    Fedyakina, Irina T.
    Veselov, Mark S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (05) : 1311 - 1324
  • [32] Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children
    Osage C.
    Barrett J.
    Hill G.
    Mann J.
    Dorr A.
    Dutkowski R.
    Ward P.
    Paediatric Drugs, 2001, 3 (3): : 229 - 236
  • [33] Synthesis and In Vitro Anti-influenza Activity of New Amino Acids and Peptidomimetics Derivatives of Oseltamivir and Rimantadine
    Stankova, Ivanka
    Chuchkov, Kiril
    Schmidtke, Michaela
    Galabov, Angel
    ANTIVIRAL RESEARCH, 2011, 90 (02) : A76 - A76
  • [34] Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate Induces Canine Mammary Cancer Cell Aggressiveness
    de Oliveira, Joana T.
    Santos, Ana L.
    Gomes, Catarina
    Barros, Rita
    Ribeiro, Claudia
    Mendes, Nuno
    de Matos, Augusto J.
    Helena Vasconcelos, M.
    Oliveira, Maria Jose
    Reis, Celso A.
    Gaertner, Fatima
    PLOS ONE, 2015, 10 (04):
  • [35] The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model
    Gerrit Frommeyer
    André Mittelstedt
    Julian Wolfes
    Christian Ellermann
    Simon Kochhäuser
    Patrick Leitz
    Dirk G. Dechering
    Lars Eckardt
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, 390 : 1155 - 1161
  • [36] Phosphonate Congeners of Oseltamivir and Zanamivir as Effective Anti-influenza Drugs: Design, Synthesis and Biological Activity
    Shie, Jiun-Jie
    Fang, Jim-Min
    JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 2014, 61 (01) : 127 - 141
  • [37] Synthesis of the anti-influenza agent (-)-oseltamivir free base and (-)-methyl 3-epi-shikimate
    Rawat, Varun
    Dey, Soumen
    Sudalai, Arumugam
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (20) : 3988 - 3990
  • [38] The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model
    Frommeyer, Gerrit
    Mittelstedt, Andre
    Wolfes, Julian
    Ellermann, Christian
    Kochhaeuser, Simon
    Leitz, Patrick
    Dechering, Dirk G.
    Eckardt, Lars
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 (11) : 1155 - 1161
  • [39] A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor Oseltamivir from 1,3-butadiene and acrylic acid
    Yeung, Ying-Yeung
    Hong, Sungwoo
    Corey, E. J.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (19) : 6310 - 6311
  • [40] Synthetic development of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (TAMIFLU™):: A challenge for process research.
    Karpf, M
    Abrecht, S
    Trussardi, R
    Wirz, B
    Zutter, U
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U69 - U69
12345